SARAH CUFFEE: Open Payments
NPI 1134672330 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 15 payments from 10 companies in 2025. Trend: 2023 $1,782 · 2024 $271 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Calliditas Therapeutics US Inc. | 1 | $119 |
| Ardelyx, Inc. | 1 | $114 |
| NxStage Medical, Inc. | 1 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Amgen Inc. | 1 | $51 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
Products named: LOKELMA, TARPEYO, XPHOZAH 30 MG, NXSTAGE SYSTEM ONE, Kerendia, JYNARQUE, REPATHA, Fabhalta.
Industry payments across WV — which companies pay providers there.
